Douglas A. Dachille insider trades

Open-market stock purchases and sales by Douglas A. Dachille, Director at BridgeBio Pharma, Inc, from SEC Form 4 filings since Sep 15, 2016.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +15%.

Recent trades

DateStockTradeValue
Jun 22, 2026BBIO BridgeBio Pharma, IncBought (not open market)—
Jun 22, 2026BBIO BridgeBio Pharma, IncBought (not open market)—
May 20, 2026EQH Equitable Holdings, IncBought (not open market)$185K
Apr 22, 2026PNC PNC Financial Services Group, IncBought (not open market)—
Apr 1, 2026PNC PNC Financial Services Group, IncBought (not open market)$6.5K
Jan 2, 2026PNC PNC Financial Services Group, IncBought (not open market)$6.6K

Companies traded

  • BBIO BridgeBio Pharma, Inc: 3 buys, last Jun 22, 2026
  • EQH Equitable Holdings, Inc: other filings, last May 20, 2026
  • PNC PNC Financial Services Group, Inc: 1 buy, last Apr 22, 2026
  • AIG American International Group, Inc: 1 sale, last Jun 29, 2021

Get free alerts when Douglas A. Dachille files a new trade →